IT7850095A0 - Peptidi e composizioni farmaceutiche che li contengono - Google Patents

Peptidi e composizioni farmaceutiche che li contengono

Info

Publication number
IT7850095A0
IT7850095A0 IT7850095A IT5009578A IT7850095A0 IT 7850095 A0 IT7850095 A0 IT 7850095A0 IT 7850095 A IT7850095 A IT 7850095A IT 5009578 A IT5009578 A IT 5009578A IT 7850095 A0 IT7850095 A0 IT 7850095A0
Authority
IT
Italy
Prior art keywords
peptides
contain
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IT7850095A
Other languages
English (en)
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IT7850095A0 publication Critical patent/IT7850095A0/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052Val-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069Ser-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/32Modification to prevent enzymatic degradation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IT7850095A 1977-06-29 1978-06-29 Peptidi e composizioni farmaceutiche che li contengono IT7850095A0 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2714077 1977-06-29

Publications (1)

Publication Number Publication Date
IT7850095A0 true IT7850095A0 (it) 1978-06-29

Family

ID=10254870

Family Applications (1)

Application Number Title Priority Date Filing Date
IT7850095A IT7850095A0 (it) 1977-06-29 1978-06-29 Peptidi e composizioni farmaceutiche che li contengono

Country Status (13)

Country Link
US (1) US4223016A (it)
EP (1) EP0000252B1 (it)
JP (1) JPS5416402A (it)
AU (1) AU522641B2 (it)
CA (1) CA1105006A (it)
DE (1) DE2861593D1 (it)
DK (1) DK292778A (it)
ES (1) ES471243A1 (it)
IE (1) IE47105B1 (it)
IL (1) IL54967A (it)
IT (1) IT7850095A0 (it)
NZ (1) NZ187638A (it)
ZA (1) ZA783699B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56119178U (it) * 1980-02-13 1981-09-11
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
US4752601A (en) * 1983-08-12 1988-06-21 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin FC receptors
EP0190127A1 (en) * 1984-08-10 1986-08-13 MERCK PATENT GmbH Immunotherapeutic polypeptide agents
US5955076A (en) * 1989-06-15 1999-09-21 Peptide Therapeutics Limited Immunoactive peptides and antibodies and their use in anti-allergy treatment
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
GB9422294D0 (en) * 1994-11-04 1994-12-21 Peptide Therapeutics Ltd Peptides for anti-allergy treatment
JP2000505077A (ja) 1996-01-16 2000-04-25 レンセレール ポリテクニック インスティチュート 骨芽細胞の接着を改良するためのペプチド
KR100498198B1 (ko) 1996-03-01 2005-09-09 노파르티스 아게 알레르기에 대한 백신접종 및 치료를 위한 펩티드 임뮤노겐
US6573372B2 (en) 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of
RU2309144C2 (ru) 2005-03-25 2007-10-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств
US7425020B2 (en) 2006-04-25 2008-09-16 Mats Lindkvist Steering wheel suspension system
ES2304223B2 (es) 2007-03-08 2009-05-01 Universidad De Sevilla Nuevos caramelos con elevado contenido en oligosacaridos prebioticos, procedimiento de preparacion y utilizacion.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6501206A (it) * 1964-02-12 1965-08-13
NL6509727A (it) * 1965-07-28 1967-01-30
US3832337A (en) * 1970-07-28 1974-08-27 Squibb & Sons Inc Peptide enzyme inhibitors
JPS5648502B2 (it) * 1972-01-17 1981-11-16
US3864481A (en) * 1972-12-14 1975-02-04 St Lukes Hospital Anti disease producing synthetic material for the prevention suppression and diagnosis of multiple sclerosis and method of treatment therefor
US3987014A (en) * 1974-01-10 1976-10-19 Becton, Dickinson And Company Secretin intermediates and derivatives
US4113858A (en) * 1975-01-20 1978-09-12 St. Luke's Hospital Novel compounds, compositions and methods of their use
FR2329293A1 (fr) * 1975-10-29 1977-05-27 Parke Davis & Co Nouveaux nonapeptides et procedes pour leur production
SE436645C (sv) * 1976-04-29 1996-07-04 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4059693A (en) * 1976-06-11 1977-11-22 University Patents, Inc. Analgesic action of substance P
US4087419A (en) * 1976-11-05 1978-05-02 Parke, Davis & Company Heptapeptides and methods for their production

Also Published As

Publication number Publication date
IE781290L (en) 1978-12-29
EP0000252B1 (en) 1982-02-03
CA1105006A (en) 1981-07-14
EP0000252A1 (en) 1979-01-10
DE2861593D1 (en) 1982-03-11
ZA783699B (en) 1979-06-27
IL54967A (en) 1982-03-31
ES471243A1 (es) 1979-10-01
IE47105B1 (en) 1983-12-28
JPS5416402A (en) 1979-02-07
US4223016A (en) 1980-09-16
DK292778A (da) 1978-12-30
AU3762878A (en) 1980-01-03
NZ187638A (en) 1981-07-13
AU522641B2 (en) 1982-06-17
IL54967A0 (en) 1978-08-31

Similar Documents

Publication Publication Date Title
SE7810591L (sv) Farmaceutiska kompositioner
FI780907A (fi) Peptider
IT1123536B (it) Derivati di spiro-ossazolidindioni e composizioni farmaceutiche che li contengono
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
BR7703469A (pt) Composicao curavel
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
NZ188170A (en) Propenylamines and pharmaceutical compositions
NZ187794A (en) 1-acyl-2-cynanoaziridines and immunestimulating pharmaceutical compositions
SE7711395L (sv) Farmaceutisk komposition
IT7850095A0 (it) Peptidi e composizioni farmaceutiche che li contengono
NZ183134A (en) I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions
BR7606292A (pt) Composicoes herbicidas e sua aplicacao
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
IT1095377B (it) Composizione farmaceutica
IT1141137B (it) Peptidi e composizioni farmaceutiche che li contengono
NZ184263A (en) N-(amino-alkyl-amino)-benzamides and pharmaceutical compositions
NZ188531A (en) W-mercapto-propionamides and pharmaceutical compositions
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
BR7700772A (pt) Composicao curavel
NZ184735A (en) Peptides and pharmaceutical compositions
IT7849938A0 (it) Composizioni farmaceutiche
BR7702372A (pt) Composicao curavel
IT7851494A0 (it) N-benzil-antracicline procedimento per prepararle e composizioni farmaceutiche che le contengono
IT7950714A0 (it) Ariltrifluoroetanoli procedimento per prepararli e composizioni farmaceutiche che li contengono